Gene · 10672
Papers1,983
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,983
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PD-L1+ diffuse large B-cell lymphoma with extremely high mutational burden and microsatellite instability due to acquired PMS2 mutation. | Cold Spring Harb Mol Case Stud | 2023 | 38199780 | PubTator, text mining | PubMed |
| Clinical outcomes of newly diagnosed primary central nervous system lymphoma treated with zanubrutinib-based combination therapy. | World J Clin Oncol | 2023 | 38179402 | PubTator, text mining | PubMed |
| Salivary Extracellular Vesicles: Biomarkers and Beyond in Human Diseases. | Int J Mol Sci | 2023 | 38139157 | PubTator, text mining | PubMed |
| Mouse models of diffuse large B cell lymphoma. | Front Immunol | 2023 | 38124747 | PubTator, text mining | PubMed |
| Optimized design and in vivo application of optogenetically functionalized Drosophila dopamine receptors. | Nat Commun | 2023 | 38114457 | PubTator, text mining | PubMed |
| Gα12 signaling regulates transcriptional and phenotypic responses that promote glioblastoma tumor invasion. | Sci Rep | 2023 | 38104152 | PubTator, text mining | PubMed |
| ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer. | Clin Epigenetics | 2023 | 38093305 | PubTator, text mining | PubMed |
| Bioinformatics analysis of human kallikrein 5 (KLK5) expression in metaplastic triple-negative breast cancer. | Cancer Innov | 2023 | 38090381 | PubTator, text mining | PubMed |
| Sulfur signaling pathway in cardiovascular disease. | Front Pharmacol | 2023 | 38074127 | PubTator, text mining | PubMed |
| Calcaneus metastasis: a rare presentation of poorly differentiated thyroid cancer. | Endocrinol Diabetes Metab Case Rep | 2023 | 38054478 | PubTator, text mining | PubMed |
| Diffuse large B-cell lymphoma with continuously elevated immunoglobulin M following treatment: a case report with pathologic, immunophenotypic, and molecular analyses. | Front Genet | 2023 | 38028606 | PubTator, text mining | PubMed |
| Competing endogenous RNAs in human astrocytes: crosstalk and interacting networks in response to lipotoxicity. | Front Neurosci | 2023 | 38027526 | PubTator, text mining | PubMed |
| Modeling the crosstalk between malignant B cells and their microenvironment in B-cell lymphomas: challenges and opportunities. | Front Immunol | 2023 | 38022603 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases. | Nat Commun | 2023 | 38007484 | PubTator, text mining | PubMed |
| Elucidation of GPR55-Associated Signaling behind THC and LPI Reducing Effects on Ki67-Immunoreactive Nuclei in Patient-Derived Glioblastoma Cells. | Cells | 2023 | 37998380 | PubTator, text mining | PubMed |
| Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy. | Cancer Cell Int | 2023 | 37981695 | PubTator, text mining | PubMed |
| CryoEM structures of adhesion in GPCR CD97: Filling in some of the gaps. | Cell Chem Biol | 2023 | 37977125 | PubTator, text mining | PubMed |
| Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation. | Invest Ophthalmol Vis Sci | 2023 | 37975847 | PubTator, text mining | PubMed |
| Oncogenic Gαq activates RhoJ through PDZ-RhoGEF. | Int J Mol Sci | 2023 | 37958718 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10672/papers?page=6